Trump considers full tariffs on imported generics

President Trump announced plans to impose tariffs of up to 100% on imported generic drugs starting in 2028, aiming to encourage domestic manufacturing. Experts are skeptical whether these tariffs alone will effectively prompt companies to reshore production, citing high costs and infrastructure requirements. The move could impact drug prices slightly and risk supply shortages if manufacturers decide to exit the U.S. market due to added financial pressures.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل